8-K: U.S. Physical Therapy Reports Strong Second Quarter with Record Patient Volume, Updates 2024 Guidance

U.S. Physical Therapy announced record patient volumes and increased revenue in the second quarter of 2024, while also updating its full-year Adjusted EBITDA guidance.

Summary

• U.S. Physical Therapy reported its second quarter 2024 results, showing an increase in patient volume and revenue.
• Adjusted EBITDA for the quarter was $22.1 million, up from $21.7 million in the same period last year.
• Operating Results were $11.0 million, or $0.73 per share, compared to $10.4 million, or $0.76 per share, in the second quarter of 2023, with the per share decrease due to an increase in shares outstanding.
• Net income attributable to USPH shareholders was $7.5 million, with earnings per share at $0.47.
• Total revenue from physical therapy operations increased by 8.5% to $143.5 million.
• The net rate per patient visit increased by 3.0% to $105.05, despite a 1.8% Medicare rate reduction.
• Average daily visits per clinic reached an all-time high of 30.6.
• Industrial injury prevention (IIP) services revenue increased by 23.2% to $23.7 million.
• The company added seven new clinics and closed five, bringing the total to 681 clinics as of June 30, 2024.
• Briotix Health Limited Partnership acquired an IIP services business for $24.0 million, which generates approximately $11.0 million in annual revenue.
• Management has updated its 2024 Adjusted EBITDA guidance, returning it to the original range of $80.0 million to $85.0 million.
• A quarterly dividend of $0.44 per share was declared, payable on September 13, 2024.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to strong revenue growth and patient volume, but tempered by increased costs and decreased profitability. The updated guidance is a positive sign, but the challenges in the employment environment and increased costs are concerning.

Positives

• The company achieved record patient volumes in the second quarter of 2024.
• Revenue from physical therapy operations increased by 8.5% year-over-year.
• The net rate per patient visit increased by 3.0%, demonstrating effective contract negotiations.
• Industrial injury prevention services revenue saw a significant increase of 23.2%.
• The company successfully acquired an IIP services business that generates $11.0 million in annual revenue.
• Management reaffirmed its original Adjusted EBITDA guidance for 2024, indicating confidence in future performance.
• The company declared a quarterly dividend of $0.44 per share.

Negatives

• Operating Results per share decreased from $0.76 to $0.73 due to an increase in shares outstanding from a secondary offering.
• Net income attributable to USPH shareholders decreased from $10.9 million to $7.5 million year-over-year.
• Salaries and related costs per visit increased to $59.66 from $57.59.
• Total operating costs per visit increased to $84.46 from $80.61.
• Gross profit margin from physical therapy operations decreased to 20.1% from 21.3%.

Risks

• The company faces challenges in the employment environment, leading to higher costs for salaries and contract labor.
• There is a higher than anticipated usage of contract therapists in several markets.
• The company is exposed to risks related to changes in Medicare rules and reimbursement rates.
• The company is subject to competitive, economic, and reimbursement conditions that may require clinic closures.
• The company's debt and financial obligations could adversely affect its financial condition.
• The company is exposed to risks related to cyber-attacks and security breaches.
• The company's business depends on hiring, training, and retaining qualified employees.

Future Outlook

Management has updated its guidance for Adjusted EBITDA for 2024, returning it to the original range of $80.0 million to $85.0 million. The company plans to continue acquiring multi-clinic outpatient physical therapy practices and companies that provide industrial injury prevention services.

Management Comments

• Chris Reading, Chief Executive Officer, said, 'Physical therapy volumes, net rate and injury prevention growth and profitability were all strong for the quarter and a result of our persistent focus in these areas.'
• Chris Reading also noted that new employees are coming in at higher rates and there is a higher than anticipated usage of contract therapists.
• Management stated that they have made significant investments in recruiting and are working to optimize their ability to address demand while maintaining a close eye on cost.

Industry Context

The results reflect a positive trend in the demand for physical therapy and industrial injury prevention services. The company's focus on increasing reimbursement rates through contract negotiations aligns with industry efforts to improve revenue streams. The acquisition of an IIP services business is consistent with the trend of consolidation and expansion in the healthcare services sector.

Comparison to Industry Standards

• U.S. Physical Therapy's revenue growth of 8.5% in physical therapy operations is solid, but it is important to compare this to other publicly traded physical therapy providers such as Select Medical (SEM) and ATI Physical Therapy (ATIP).
• The increase in net rate per patient visit by 3.0% is a positive sign, but it should be benchmarked against industry averages and the performance of competitors.
• The company's Adjusted EBITDA of $22.1 million is a key metric, and its performance should be compared to the EBITDA margins of its peers.
• The acquisition of an IIP services business for $24.0 million is a strategic move, and its success should be evaluated against similar acquisitions in the industry.
• The company's clinic count of 681 should be compared to the clinic networks of its competitors to assess its market position.

Stakeholder Impact

• Shareholders will receive a quarterly dividend of $0.44 per share.
• Employees may experience changes in compensation and work environment due to the company's efforts to address staffing challenges.
• Customers will benefit from the company's continued expansion and focus on providing quality physical therapy and industrial injury prevention services.
• Suppliers may see increased demand for their products and services as the company continues to grow.

Next Steps

• The company will continue to focus on optimizing its ability to address demand while maintaining a close eye on cost and related expense management.
• The company will continue to acquire multi-clinic outpatient physical therapy practices and companies that provide industrial injury prevention services.
• The company will file its Quarterly Report on Form 10-Q with the Securities and Exchange Commission on August 14, 2024.
• Management will host a conference call on August 14, 2024, to discuss the financial results.

Key Dates

Keywords

physical therapy, industrial injury prevention, EBITDA, revenue, patient volume, clinic operations, acquisitions, dividends, healthcare, reimbursement rates